
CAS
875787-07-8
Formulation
A crystalline solid
Purity
≥98%
MW
422,8
Shipment
-20
Long Term Storage
-20
Shelf Life
1460
Description
An LXR modulator that acts as a partial agonist at LXRα and a full agonist at LXRβ (IC50s = 179 and 24 nM, respectively); orally bioavailable and readily passes the BBB; anti-atherogenic in animal models of atherosclerosis
ESCLUSIVAMENTE PER USO DI RICERCA (RUO) e non per uso terapeutico o diagnostico su uomini o animali. Il prodotto NON è un Dispositivo Medico o un Diagnostico in Vitro.
PRODUCT FOR RESEARCH USE ONLY (RUO) and not for therapeutic or diagnostic use on humans or animals. The product is NOT a Medical Device or an In-Vitro Diagnostic (IVD).